In adenine-based diets in CKD animals, phosphate binders can restore CKD-induced hyperphosphatemia, decrease FGF-23 levels, and diminish urinary phosphate excretion, and they concurrently alleviate calcium and phosphate contents in the aorta. The gene discussed is FGF23; the disease is chronic kidney disease.